Dutch medical device manufacturer Philips has reached a preliminary agreement with the US Department of Justice to resolve investigations linked to its 2021 global recall of sleep and respiratory-care devices. The company booked a €288 million provision in Q3 related to the settlement.
Pharmacies are warning that patients are increasingly using AI-edited photographs to make themselves appear heavier in order to fraudulently access weight-loss treatments such as Mounjaro and Wegovy. The pharmacies are calling for tougher verification checks to prevent such deceptions.
The US FDA warned Amgen that a promotional video for its colorectal cancer drug Vectibix was misleading because it highlighted benefits while failing to adequately disclose serious safety risks and patient limitations. The warning letter was issued on Tuesday.
The Federal Election Commission has been unable to perform most of its duties, including advising campaigns or investigating alleged violations of campaign finance law, as the 2026 midterm elections approach. The agency's incapacitation leaves a significant gap in oversight of campaign spending and finance regulations during the election cycle.
The European Commission accepted Sanofi's commitments to end an antitrust investigation into allegations the company disparaged CSL Seqirus' competing flu vaccine. The commitments will become legally binding for Sanofi, allowing it to avoid a fine.
The U.S. Department of Justice is expanding its antitrust investigation into Fox's $22 billion deal to acquire streaming platform Roku, with DOJ staff planning to seek additional information from the companies involved.
A Michigan state court issued a preliminary injunction barring prediction-market platform Kalshi from offering services in the state, with Judge Rosemarie Aquilina threatening a $500,000 daily fine. Separately, New Jersey filed a petition for Supreme Court review seeking clarity on regulatory authority over prediction markets.
The FDA has implemented a new policy that will permit some flavored vaping products to stay on the market without agency authorization, raising concerns among public health experts after the agency previously warned about harmful kratom-derived products.